Videos

Kathryn Ciccolini, RN, BSN, OCN, DNC, Memorial Sloan Kettering Cancer Center, discusses the increase of dermatologic adverse events with new cancer therapies.

Colleen O’Leary, associate director for nursing education, The Ohio State University James Cancer Hospital, discusses the vital role nurses play in guiding the treatment of their patients with cancer.

Inna Tsuker, PharmD, BCPS, Cancer Treatment Centers of America, discusses a team-based approach implemented to prevent patients with cancer from falling.

Darcy Burbage, RN, MSN, AOCN, CBCN, Helen F. Graham Cancer Center & Research Institute, discusses risk factors that oncology nurses should be aware of when thinking about chemotherapy-induced peripheral neuropathy (CIPN).

​Joan Lockhart, PhD, RN, CORLN, AOCN, CNE, ANEF, FAAN, clinical professor at Duquesne University School of Nursing, discusses issues oncology nurses should monitor for when treating patients with head and neck cancer.

Paloma Pearson, manager of clinical operations, Baylor Scott and White Hillcrest Medical Center, talks about how technology is changing the landscape of healthcare.

Caitlin Braithwaite, BAN, RN, OCN, University of Iowa Hospitals and Clinics, discusses her use of hand massage in patients with cancer, and what her fellow nurses thought of the implementation.

Meredith Buxton, PhD, University of California San Francisco, discusses the I-SPY 2 trial, for which she is the executive director.

Norman E. Sharpless, MD, Professor of Medicine & Genetics Chair, The Lineberger Comprehensive Cancer Center, discusses a recent study that evaluated sunscreen’s effectiveness in reducing melanoma risk.

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses nurses’ roles in treating patients receiving immunotherapy, especially combination checkpoint blockades, which are typically associated with higher risks of adverse events.

Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.

Mario E. Lacouture, MD, dermatologist, Memorial Sloan Kettering Cancer Center, discusses some of the adverse effects of newly approved targeted therapies.

Jae Park, MD, Memorial Sloan Kettering Cancer Center, explains CAR T-cell therapy, which is currently being investigated in patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma.

Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the great strides in kidney cancer care that have been made in the past decade.

Oliver Sartor, MD, Medical Director Tulane Cancer Center, discusses when he administers Radium-223 in his practice.

Sarah B. Goldberg, MD, MPH, assistant professor of medicine at Yale Cancer Center, discusses new treatment options for patients with non-small cell lung cancer (NSCLC).

Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses misconceptions women have about being pregnant with a breast cancer diagnosis.

Kevin Hughes, MD, FACS, breast surgeon, Massachusetts General Hospital, discusses the impact of lumpectomies on elderly patients with breast cancer.

Rajni Kannan, BS, MS, RN, ANP-BC, from Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses the adverse events (AEs) commonly seen with combinations of therapies to treat melanoma.

Kimberly J. Van Zee, MS, MD, FACS, discusses difficult decisions women with a Ductal carcinoma in situ (DCIS) diagnosis face.

Andrew D. Zelenetz, Md, PhD, medical director of quality informatics at Memorial Sloan Kettering Cancer Center, discusses what patients often do not tell their doctors but discuss with their nurses.

Kilian Salerno, director of Breast Radiation and Soft Tissue/Melanoma Radiation, Roswell Park Cancer Center, discusses assessing cancer risk.

E. David Crawford, MD, professor of radiation oncology University of Colorado Denver, discusses the potential side effects of frequently used prostate cancer treatments.

Oliver Sartor, MD, Medical Director Tulane Cancer Center, discusses some of the most common questions patients have when starting treatment with Radium-223, and how nurses can play a role in patient education.

​Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the role that nurses will play in the shifting paradigm of cancer treatment.

​David Steensma, MD, Dana-Farber Cancer Institute, discusses treatment options for myelodysplastic syndromes. 

Jae Park, MD, hematologist-oncologist, Memorial Sloan Kettering Cancer Center, talks about CAR T-cell activation therapy, which is currently in clinical trials for patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma.

​Sarah B. Goldberg, MD, MPH, assistant professor of medicine at Yale Cancer Center, discusses the side effects of immunotherapy on patients with non-small cell lung cancer.